#152856

D38 Cell Line

Please Enter Your Email ID
Email ID

Cat. #152856

D38 Cell Line

Cat. #: 152856

Unit size: 1x10^6 cells / vial

Organism: Human

Tissue: Tongue

Disease: Cancer

Model: Tumour line

£575.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Paul Harrison

Institute: Cancer Research UK, Glasgow: The Beatson Institute

Tool Details
Handling
Related Tools
References

Tool Details

*FOR RESEARCH USE ONLY

  • Name: D38 Cell Line
  • Cancer: Blood cancer
  • Cancers detailed: Dysplasia;Leukoplakia
  • Research fields: Cancer;Drug development
  • Organism: Human
  • Tissue: Tongue
  • Disease: Cancer
  • Model: Tumour line
  • Conditional: No
  • Description: D38 Cell Line is derived from a leukoplakia biopsy. The cell line was notable in its proliferative capacity, considered immortal after having completed more than 100 PDs (population doublings ) when maintained on a feeder layer of irradiated 3T3 fibroblasts. D38 was categorised as having a mild dysplasia pathology.
  • Production details: Biopsies were trypsinized and cultured until a growing population of cells was obtained in a 9-cm plate and then passaged once to give a stock culture that was frozen. All cells were maintained on irradiated 3T3 feeders, in 10H medium. The 3T3 feeder layer was removed by treatment with 0.02% EDTA prior to RNA and protein extraction.
  • Cellosaurus id: CVCL_HF99

Handling

  • Format: Frozen
  • Growth medium: As per Cancer Res. 1997 Sep 15;57(18):3886-9. All cells were maintained on irradiated 3T3 feeders, in 10H medium (DMEM plus 10% FCS without added growth factors except hydrocortisone).
  • Unit size: 1x10^6 cells / vial
  • Shipping conditions: Dry ice

Related Tools

  • Related tools: D34 Cell Line

References

  • McGregor et al. 2002. Cancer Res. 62(16):4757-66. PMID: 12183435.
  • Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.